Medicine recalls
|
| |
| Canada: Recall: AG Telmisartan-HCT Tablet: Out of specification (Assay) |
| |
Health Canada announces that JAMP Pharma Corporation is recalling one lot of AG Telmisartan-HCT Tablet (telmisartan 80 mg, hydrochlorothiazide 25 mg) (lot number: EG23AGL002) from retailers because the assay in telmisartan is out of specification in the affected lot.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/ag-telmisartan-hct-tablet-out-specification-assay
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Thursday, Sep 12, 2024
Issued at HKT 15:30
|
| |
